Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$11,348,460
+$2,128,624 QoQ
Shares Held
45,098
+6.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#864
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bogart Wealth, LLC holds $67,404,111 across 15 Drug Manufacturers - General names. ABBV ranks #4 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,936 | $15,515,827 | |
| 2 | PFE |
Pfizer Inc
|
512,324 | $12,336,761 | |
| 3 | JNJ |
Johnson & Johnson
|
45,347 | $11,516,777 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
45,098 | $11,348,460 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
70,149 | $8,862,624 | |
| 6 | AMGN |
Amgen Inc
|
17,354 | $6,284,230 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,849 | $1,008,596 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,344 | $135,061 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,348,460 | 45,098 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $9,219,836 | 42,392 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $980,907 | 4,293 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $881,241 | 3,806 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $713,337 | 3,843 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $842,898 | 4,023 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $749,005 | 4,215 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $734,625 | 3,720 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $652,633 | 3,805 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $874,626 | 4,803 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $9,268,910 | 59,811 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,074,027 | 60,875 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $8,213,679 | 60,964 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $9,615,748 | 60,336 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $11,756,965 | 72,749 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $9,173,790 | 68,354 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $8,878,072 | 57,966 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $7,895,405 | 48,704 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $7,743,255 | 57,188 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $5,890,457 | 54,607 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $5,813,463 | 51,611 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,910,698 | 45,377 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $3,749,285 | 34,991 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $2,896,776 | 33,072 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $3,310,433 | 33,718 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,582,002 | 33,889 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||